Compendium of Cancer Genome Aberrations

Bailey.Glen

Joined 17 December 2021

User:Bailey.Glen (view source)

Revision as of 12:28, 26 January 2024

5,345 bytes added ,  26 January
no edit summary
Line 10: Line 10:  
!'''Date of Last Editor Review'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
!'''Notes'''
−
|-|[[BRST5:Usual_ductal_hyperplasia|Usual ductal hyperplasia]]
+
|-
 +
 
 +
|[[CNS5:Astrocytoma,_IDH-mutant|Astrocytoma, IDH-mutant]]
 
|Disease
 
|Disease
 
|
 
|
Line 20: Line 22:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Columnar_cell_lesions,_including_flat_epithelial_atypia_|Columnar cell lesions, including flat epithelial atypia ]]
+
|-
 +
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]
 
|Disease
 
|Disease
 
|
 
|
Line 30: Line 33:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Atypical_ductal_hyperplasia|Atypical ductal hyperplasia]]
+
|-
 +
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]
 
|Disease
 
|Disease
 
|
 
|
Line 40: Line 44:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Sclerosing_adenosis|Sclerosing adenosis]]
+
|-
 +
|[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
 
|Disease
 
|Disease
 
|
 
|
Line 50: Line 55:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Apocrine_adenosis_and_adenoma|Apocrine adenosis and adenoma]]
+
|-
 +
|[[CNS5:Angiocentric_glioma|Angiocentric glioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 60: Line 66:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Microglandular_adenosis_|Microglandular adenosis ]]
+
|-
 +
|[[CNS5:Polymorphous_low-grade_neuroepithelial_tumour_of_the_young|Polymorphous low-grade neuroepithelial tumour of the young]]
 
|Disease
 
|Disease
 
|
 
|
Line 70: Line 77:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Radial_scar_/_complex_sclerosing_lesion_|Radial scar / complex sclerosing lesion ]]
+
|-
 +
|[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered ]]
 
|Disease
 
|Disease
 
|
 
|
Line 80: Line 88:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Tubular_adenoma_|Tubular adenoma ]]
+
|-
 +
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
 
|Disease
 
|Disease
 
|
 
|
Line 90: Line 99:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Lactating_adenoma_|Lactating adenoma ]]
+
|-
 +
|[[CNS5:Diffuse_hemispheric_glioma,_H3_G34-mutant|Diffuse hemispheric glioma, H3 G34-mutant]]
 
|Disease
 
|Disease
 
|
 
|
Line 100: Line 110:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Ductal_adenoma|Ductal adenoma]]
+
|-
 +
|[[CNS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]
 
|Disease
 
|Disease
 
|
 
|
Line 110: Line 121:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Pleomorphic_adenoma|Pleomorphic adenoma]]
+
|-
 +
|[[CNS5:Infant-type_hemispheric_glioma|Infant-type hemispheric glioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 120: Line 132:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Adenomyoepithelioma|Adenomyoepithelioma]]
+
|-
 +
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma ]]
 
|Disease
 
|Disease
 
|
 
|
Line 130: Line 143:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Malignant_adenomyoepithelioma|Malignant adenomyoepithelioma]]
+
|-
 +
|[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]
 
|Disease
 
|Disease
 
|
 
|
Line 140: Line 154:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Intraductal_papilloma|Intraductal papilloma]]
+
|-
 +
|[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 150: Line 165:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Papillary_ductal_carcinoma_in_situ|Papillary ductal carcinoma in situ]]
+
|-
 +
|[[CNS5:Subependymal_giant_cell_astrocytoma|Subependymal giant cell astrocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 160: Line 176:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Encapsulated_papillary_carcinoma|Encapsulated papillary carcinoma]]
+
|-
 +
|[[CNS5:Chordoid_glioma|Chordoid glioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 170: Line 187:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Solid_papillary_carcinoma_(in_situ_and_invasive)|Solid papillary carcinoma (in situ and invasive)]]
+
|-
 +
|[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]
 
|Disease
 
|Disease
 
|
 
|
Line 180: Line 198:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Invasive_papillary_carcinoma|Invasive papillary carcinoma]]
+
|-
 +
|[[CNS5:Ganglioglioma|Ganglioglioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 190: Line 209:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Atypical_lobular_hyperplasia_|Atypical lobular hyperplasia ]]
+
|-
 +
|[[CNS5:Gangliocytoma|Gangliocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 200: Line 220:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Lobular_carcinoma_in_situ|Lobular carcinoma in situ]]
+
|-
 +
|[[CNS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 210: Line 231:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Ductal_carcinoma_in_situ_|Ductal carcinoma in situ ]]
+
|-
 +
|[[CNS5:Dysembryoplastic_neuroepithelial_tumour|Dysembryoplastic neuroepithelial tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 220: Line 242:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Invasive_breast_carcinoma:_General_overview|Invasive breast carcinoma: General overview]]
+
|-
 +
|[[CNS5:Diffuse_glioneuronal_tumour_with_oligodendroglioma-like_features_and_nuclear_clusters|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters]]
 
|Disease
 
|Disease
 
|
 
|
Line 230: Line 253:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Invasive_breast_carcinoma_of_no_special_type|Invasive breast carcinoma of no special type]]
+
|-
 +
|[[CNS5:Papillary_glioneuronal_tumour|Papillary glioneuronal tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 240: Line 264:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Microinvasive_carcinoma|Microinvasive carcinoma]]
+
|-
 +
|[[CNS5:Rosette-forming_glioneuronal_tumour|Rosette-forming glioneuronal tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 250: Line 275:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Invasive_lobular_carcinoma_|Invasive lobular carcinoma ]]
+
|-
 +
|[[CNS5:Myxoid_glioneuronal_tumour|Myxoid glioneuronal tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 260: Line 286:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Tubular_carcinoma|Tubular carcinoma]]
+
|-
 +
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 270: Line 297:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Cribriform_carcinoma|Cribriform carcinoma]]
+
|-
 +
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 280: Line 308:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Mucinous_carcinoma|Mucinous carcinoma]]
+
|-
 +
|[[CNS5:Dysplastic_cerebellar_gangliocytoma_(Lhermitte-Duclos_disease)|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)]]
 
|Disease
 
|Disease
 
|
 
|
Line 290: Line 319:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Mucinous_cystadenocarcinoma|Mucinous cystadenocarcinoma]]
+
|-
 +
|[[CNS5:Central_neurocytoma|Central neurocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 300: Line 330:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Invasive_micropapillary_carcinoma|Invasive micropapillary carcinoma]]
+
|-
 +
|[[CNS5:Extraventricular_neurocytoma|Extraventricular neurocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 310: Line 341:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Carcinoma_with_apocrine_differentiation|Carcinoma with apocrine differentiation]]
+
|-
 +
|[[CNS5:Cerebellar_liponeurocytoma|Cerebellar liponeurocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 320: Line 352:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Metaplastic_carcinoma|Metaplastic carcinoma]]
+
|-
 +
|[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 330: Line 363:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Acinic_cell_carcinoma|Acinic cell carcinoma]]
+
|-
 +
|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive ]]
 
|Disease
 
|Disease
 
|
 
|
Line 340: Line 374:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Adenoid_cystic_carcinoma|Adenoid cystic carcinoma]]
+
|-
 +
|[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]
 
|Disease
 
|Disease
 
|
 
|
Line 350: Line 385:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Secretory_carcinoma_|Secretory carcinoma ]]
+
|-
 +
|[[CNS5:Posterior_fossa_ependymoma|Posterior fossa ependymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 360: Line 396:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Mucoepidermoid_carcinoma|Mucoepidermoid carcinoma]]
+
|-
 +
|[[CNS5:Posterior_fossa_group_A_(PFA)_ependymoma|Posterior fossa group A (PFA) ependymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 370: Line 407:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Polymorphous_adenocarcinoma|Polymorphous adenocarcinoma]]
+
|-
 +
|[[CNS5:Posterior_fossa_group_B_(PFB)_ependymoma|Posterior fossa group B (PFB) ependymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 380: Line 418:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Tall_cell_carcinoma_with_reversed_polarity|Tall cell carcinoma with reversed polarity]]
+
|-
 +
|[[CNS5:Spinal_ependymoma|Spinal ependymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 390: Line 429:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Neuroendocrine_tumour|Neuroendocrine tumour]]
+
|-
 +
|[[CNS5:Spinal_ependymoma,_MYCN-amplified|Spinal ependymoma, MYCN-amplified]]
 
|Disease
 
|Disease
 
|
 
|
Line 400: Line 440:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Neuroendocrine_carcinoma|Neuroendocrine carcinoma]]
+
|-
 +
|[[CNS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 410: Line 451:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Hamartoma_|Hamartoma ]]
+
|-
 +
|[[CNS5:Subependymoma|Subependymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 420: Line 462:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Fibroadenoma_|Fibroadenoma ]]
+
|-
 +
|[[CNS5:Choroid_plexus_papilloma|Choroid plexus papilloma]]
 
|Disease
 
|Disease
 
|
 
|
Line 430: Line 473:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Phyllodes_tumour_|Phyllodes tumour ]]
+
|-
 +
|[[CNS5:Atypical_choroid_plexus_papilloma|Atypical choroid plexus papilloma]]
 
|Disease
 
|Disease
 
|
 
|
Line 440: Line 484:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Syringomatous_tumour_|Syringomatous tumour ]]
+
|-
 +
|[[CNS5:Choroid_plexus_carcinoma|Choroid plexus carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 450: Line 495:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Nipple_adenoma_|Nipple adenoma ]]
+
|-
 +
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
 
|Disease
 
|Disease
 
|
 
|
Line 460: Line 506:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Paget_disease_of_the_breast|Paget disease of the breast]]
+
|-
 +
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-wildtype|Medulloblastoma, SHH-activated and TP53-wildtype]]
 
|Disease
 
|Disease
 
|
 
|
Line 470: Line 517:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Haemangioma|Haemangioma]]
+
|-
 +
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
 
|Disease
 
|Disease
 
|
 
|
Line 480: Line 528:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Angiomatosis|Angiomatosis]]
+
|-
 +
|[[CNS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]
 
|Disease
 
|Disease
 
|
 
|
Line 490: Line 539:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Atypical_vascular_lesions_|Atypical vascular lesions ]]
+
|-
 +
|[[CNS5:Medulloblastoma,_histologically_defined|Medulloblastoma, histologically defined]]
 
|Disease
 
|Disease
 
|
 
|
Line 500: Line 550:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Postradiation_angiosarcoma_of_the_breast|Postradiation angiosarcoma of the breast]]
+
|-
 +
|[[CNS5:Atypical_teratoid/rhabdoid_tumour|Atypical teratoid/rhabdoid tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 510: Line 561:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Primary_angiosarcoma_of_the_breast|Primary angiosarcoma of the breast]]
+
|-
 +
|[[CNS5:Cribriform_neuroepithelial_tumour|Cribriform neuroepithelial tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 520: Line 572:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Nodular_fasciitis|Nodular fasciitis]]
+
|-
 +
|[[CNS5:Embryonal_tumour_with_multilayered_rosettes|Embryonal tumour with multilayered rosettes]]
 
|Disease
 
|Disease
 
|
 
|
Line 530: Line 583:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Myofibroblastoma|Myofibroblastoma]]
+
|-
 +
|[[CNS5:CNS_neuroblastoma,_FOXR2-activated|CNS neuroblastoma, FOXR2-activated]]
 
|Disease
 
|Disease
 
|
 
|
Line 540: Line 594:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Desmoid_fibromatosis_|Desmoid fibromatosis ]]
+
|-
 +
|[[CNS5:CNS_tumour_with_BCOR_internal_tandem_duplication|CNS tumour with BCOR internal tandem duplication]]
 
|Disease
 
|Disease
 
|
 
|
Line 550: Line 605:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Inflammatory_myofibroblastic_tumour_|Inflammatory myofibroblastic tumour ]]
+
|-
 +
|[[CNS5:CNS_embryonal_tumour_NEC/NOS|CNS embryonal tumour NEC/NOS]]
 
|Disease
 
|Disease
 
|
 
|
Line 560: Line 616:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Schwannoma_|Schwannoma ]]
+
|-
 +
|[[CNS5:Pineocytoma|Pineocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 570: Line 627:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Neurofibroma_|Neurofibroma ]]
+
|-
 +
|[[CNS5:Pineal_parenchymal_tumour_of_intermediate_differentiation|Pineal parenchymal tumour of intermediate differentiation]]
 
|Disease
 
|Disease
 
|
 
|
Line 580: Line 638:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Granular_cell_tumour|Granular cell tumour]]
+
|-
 +
|[[CNS5:Pineoblastoma|Pineoblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 590: Line 649:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Leiomyoma|Leiomyoma]]
+
|-
 +
|[[CNS5:Papillary_tumour_of_the_pineal_region|Papillary tumour of the pineal region]]
 
|Disease
 
|Disease
 
|
 
|
Line 600: Line 660:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Leiomyosarcoma_|Leiomyosarcoma ]]
+
|-
 +
|[[CNS5:Desmoplastic_myxoid_tumour_of_the_pineal_region,_SMARCB1-mutant|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant]]
 
|Disease
 
|Disease
 
|
 
|
Line 610: Line 671:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Lipoma_|Lipoma ]]
+
|-
 +
|[[CNS5:Schwannoma|Schwannoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 620: Line 682:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Angiolipoma_|Angiolipoma ]]
+
|-
 +
|[[CNS5:Neurofibroma|Neurofibroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 630: Line 693:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Liposarcoma_|Liposarcoma ]]
+
|-
 +
|[[CNS5:Perineurioma|Perineurioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 640: Line 704:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Pseudoangiomatous_stromal_hyperplasia|Pseudoangiomatous stromal hyperplasia]]
+
|-
 +
|[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]]
 
|Disease
 
|Disease
 
|
 
|
Line 650: Line 715:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Extranodal_marginal_zone_lymphoma_of_mucosa-associated_lymphoid_tissue_(MALT_lymphoma)|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)]]
+
|-
 +
|[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 660: Line 726:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Follicular_lymphoma_|Follicular lymphoma ]]
+
|-
 +
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 670: Line 737:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Diffuse_large_B-cell_lymphoma_|Diffuse large B-cell lymphoma ]]
+
|-
 +
|[[CNS5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
 
|Disease
 
|Disease
 
|
 
|
Line 680: Line 748:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Burkitt_lymphoma|Burkitt lymphoma]]
+
|-
 +
|[[CNS5:Meningioma|Meningioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 690: Line 759:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Breast_implant-associated_anaplastic_large_cell_lymphoma_|Breast implant-associated anaplastic large cell lymphoma ]]
+
|-
 +
|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 700: Line 770:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Gynaecomastia|Gynaecomastia]]
+
|-
 +
|[[CNS5:Haemangiomas_and_vascular_malformations|Haemangiomas and vascular malformations]]
 
|Disease
 
|Disease
 
|
 
|
Line 710: Line 781:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Carcinoma_in_situ|Carcinoma in situ]]
+
|-
 +
|[[CNS5:Haemangioblastoma|Haemangioblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 720: Line 792:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Invasive_carcinoma|Invasive carcinoma]]
+
|-
 +
|[[CNS5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 730: Line 803:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Metastases_to_the_breast|Metastases to the breast]]
+
|-
 +
|[[CNS5:Intracranial_mesenchymal_tumour,_FET::CREB_fusion-positive|Intracranial mesenchymal tumour, FET::CREB fusion-positive]]
 
|Disease
 
|Disease
 
|
 
|
Line 740: Line 814:  
|
 
|
 
|
 
|
−
|-|[[BRST5:BRCA1/2-associated_hereditary_breast_and_ovarian_cancer_syndrome|BRCA1/2-associated hereditary breast and ovarian cancer syndrome]]
+
|-
 +
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 750: Line 825:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Cowden_syndrome|Cowden syndrome]]
+
|-
 +
|[[CNS5:Primary_intracranial_sarcoma,_DICER1-mutant|Primary intracranial sarcoma, DICER1-mutant]]
 
|Disease
 
|Disease
 
|
 
|
Line 760: Line 836:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Ataxia-telangiectasia|Ataxia-telangiectasia]]
+
|-
 +
|[[CNS5:Ewing_sarcoma|Ewing sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 770: Line 847:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Li-Fraumeni_syndrome,_TP53-associated|Li-Fraumeni syndrome, TP53-associated]]
+
|-
 +
|[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 780: Line 858:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Li-Fraumeni_syndrome,_CHEK2-associated|Li-Fraumeni syndrome, CHEK2-associated]]
+
|-
 +
|[[CNS5:Chondrosarcoma|Chondrosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 790: Line 869:  
|
 
|
 
|
 
|
−
|-|[[BRST5:CDH1-associated_breast_cancer|CDH1-associated breast cancer]]
+
|-
 +
|[[CNS5:Chordoma|Chordoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 800: Line 880:  
|
 
|
 
|
 
|
−
|-|[[BRST5:PALB2-associated_cancers|PALB2-associated cancers]]
+
|-
 +
|[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 810: Line 891:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]]
+
|-
 +
|[[CNS5:Circumscribed_meningeal_melanocytic_neoplasms:_Melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 820: Line 902:  
|
 
|
 
|
 
|
−
|-|[[BRST5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
+
|-
 +
|[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Other_low-grade_B-cell_lymphomas_of_the_CNS|Other low-grade B-cell lymphomas of the CNS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Anaplastic_large_cell_lymphoma_(ALK+/ALK−)|Anaplastic large cell lymphoma (ALK+/ALK−)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Histiocytic_sarcoma|Histiocytic sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Germ_cell_tumours_of_the_CNS|Germ cell tumours of the CNS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Pituicytoma,_granular_cell_tumour_of_the_sellar_region,_and_spindle_cell_oncocytoma|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Pituitary_blastoma|Pituitary blastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Metastases_to_the_brain_and_spinal_cord_parenchyma|Metastases to the brain and spinal cord parenchyma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Metastases_to_the_meninges|Metastases to the meninges]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Schwannomatosis|Schwannomatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Cowden_syndrome|Cowden syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Carney_complex|Carney complex]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:DICER1_syndrome|DICER1 syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Melanoma-astrocytoma_syndrome|Melanoma-astrocytoma syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Familial_retinoblastoma|Familial retinoblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Fanconi_anaemia|Fanconi anaemia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Retrieved from "https://ccga.io/index.php/Special:MobileDiff/14121...14124"